Background: Frequent wheezing in original asthma predictive index (API) was defined
| INTRODUCTION
Asthma predictive index (API) was developed to predict asthma at school age using factors that were found during the first 3 years of life 1 and suggested to ascertain asthma status for a timely treatment by NAEPP guidelines. 2 The original API study did not define the specific number of wheezing episodes for "frequent wheezer" assessed by annual questionnaire, but was based on parent's response to a five-item Likert scale to measure the frequency of wheezing episodes (ie, "frequent wheezing" which is a prerequisite for API was defined by a value of ≥3 on a scale of 1 ["very rarely"] to 5 ["on most days"]). 1 Other modified API such as mAPI, m 2 API, and ucAPI required frequent wheezing defined by the number of wheezing episodes (eg, 2 or 4) within the past 12 months, although they used wheezing frequency during the child's first 3 years of life. [3] [4] [5] For example, modified API (mAPI) required 4 or more wheezing episodes in the past 1 year, whereas m 2 API and University of Cincinnati API (ucAPI) are based on 2 or more episodes of wheezing during the same period. [3] [4] [5] The original API is the only algorithm to predict asthma that was performed in a general population. Its major strength is its good positive likelihood ratio (LR)~7.4 (the effect on post-test probability of disease improved significantly), but because its sensitivity is modest, it is limited to identify asthma 6, 7 and has not been applied to retrospective studies based on medical records until recently by
Wi et al 8, 9 Given that there is no gold standard for a diagnosis of asthma, it is challenging to define (i) how many wheezing episodes and (ii) over what period of time at any given time point constitutes "frequent wheezing" in terms of ascertaining asthma status, particularly if API is applied to retrospective studies using medical records (eg, 2 vs 3 or more wheezing episodes within 1 year vs 3 year interval between wheezing episodes). As the needs and trends of utilizing retrospective data based on medical records for asthma research grow, a suitable operational definition of API for retrospective studies based on medical records is warranted.
Specifically, it is unclear whether a one-year period (a prior year) is a suitable interval for counting the number of wheezing episodes documented in medical records to define "frequent wheezing" to apply API. Addressing this question is important when one applies API to retrospective studies using medical records of children, particularly aged over 3 years. Given that wheezing intervals among children with asthma may increase with age and the frequency of wheezing decreases with age, wheezing intervals need to reflect this age-dependent change and be broadened. To address this question, we conducted a retrospective cohort study, which followed a random sample of 
| Study setting
Rochester, Minnesota, is centrally located in Olmsted County. During the study period, characteristics of the City of Rochester and
Olmsted County populations were similar to those of the U.S.
White population, with the exception of a higher proportion of the working population employed in the healthcare industry. [13] [14] [15] Health care in Olmsted County, Minnesota, is virtually self-contained within the community, and when patients register with any healthcare providers in the community for the first time, they are asked whether they authorize using their medical records for research. If one grants the authorization (95%) for using medical record for research, each patient is assigned a unique identifier under the auspices of the Rochester Epidemiology Project (REP), which links all inpatient and outpatient clinical diagnoses and information from every episode of care to each patient and healthcare provider. 17 St.
Sauver et al 17 reported that about 95% of children living in Olmsted County who participated in the REP were followed during their study period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . This unique longitudinal populationbased resource has been continuously funded by the NIH since 1966 and has been the source of over 2000 publications on the epidemiology of disease. [18] [19] [20] [21] Our previous study showed that parents sought medical evaluation for 1 of 3 mild acute illnesses of their children in our study setting, 22 while about 1 of 4 (217/800) children and adults with illnesses or injuries visited a clinician's office nationally. 23 
| Study subjects
The study utilized a part of the 2002-2006 population-based birth cohort born at Mayo Clinic in Rochester, Minnesota, who had been enrolled in a previous asthma study. 24 Study subjects of this study were obtained from the original study designed to examine the relationship between late-preterm infancy and the risk of asthma. Briefly, the original study enrolled 579 subjects comprised of 282 late-preterm infants (34 0/7 to 36 6/7 weeks of gestation) and 297 gender-and WI ET AL.
| 1277 birth year-matched term infants (37 0/7 to 40 6/7 weeks of gestation) randomly selected from the 2002 to 2006 birth cohort born in Olmsted County, Minnesota. In this study, a total of 152 subjects were excluded due to the following reasons: (i) change in research authorization status (n = 17), (ii) non-Mayo Clinic patients (n = 132), and (iii) adopted children (n = 3; API requires checking biological parental history for asthma as one of major criteria), leaving 427 study subjects eligible for this study. The children excluded (n = 152), compared to those not excluded (n = 427), had similar proportion of female, family history of asthma, eczema, and allergic rhinitis, but tend to be nonWhite and late-preterm (data not shown). Among them, 62 subjects met the API criteria without regard to wheezing interval (ie, no interval limit) and were included in this study.
| Asthma ascertainment by asthma predictive index (API)
We operationalized the API criteria for a retrospective study, and the details were previously reported. 8, 9 It is delineated in Table 1 .
Briefly, we identified all wheezing episodes with an interval of at least 3 weeks 10-12 between recurrent wheezing episodes as well as the minimal wheezing interval (in years) for recurrent (2 or more)
wheezing episodes. [10] [11] [12] If the subject had recurrent (ie, 2 or more)
wheezing episodes, major and minor criteria of API were applied. A physician diagnosis of atopic dermatitis (or eczema) and allergic rhinitis (or hay fever) of patients and parental history of asthma were obtained from their medical records, which includes information on present family history provided by parents on a regular basis at each clinic visit. As for the item of "wheezing apart from cold," "cold" was defined by upper respiratory infection or cold documented, OR fever (≥100.4°F) plus runny or stuffy nose documented in medical records.
Eosinophilia was considered to be present if eosinophils were ≥ 4% of the total white blood cells in the test performed during study period for any purpose.
| Statistical analysis
We summarized characteristics of study subjects. The main aim of the analysis was to assess the intervals of wheezing episodes and characterize the intervals with regard to pertinent sociodemographic and clinical characteristics. Wheezing intervals of subjects who had at least two wheezing episodes with at least a 3-week interval were analyzed. For those with multiple wheezing episodes, we collected the information on intervals for two separate wheezing episodes.
For example, if a patient had three wheezing episodes during the study period, two intervals (ie, between 1st and 2nd episode and between 2nd and 3rd episode) were recorded. At the same time, we also collected data on the frequency of wheezing episodes within a one-, two-, and three-year interval at any given time since the first wheezing episode. The means and medians of intervals between wheezing episodes were calculated and then analyzed in relation to age. For the relationship between other characteristics and intervals, we used t test for continuous variable and chi-square test for categorical variables. All analyses were performed using JMP statistical software package (Ver 10; SAS Institute, Inc, Cary, NC, USA).
3 | RESULTS
| Characteristics of study subjects
Characteristics of study subjects are summarized in Table 2 . Among 62 eligible children, 58% were males, 77% were Whites, and the median age at the time of asthma onset by API and at last follow-up date was 2.3 years (IQR: 1.3, 5.5) and 11.3 years (IQR: 9.5, 12.1),
T A B L E 1 Operationalization of the original asthma predictive index (API)
Original asthma predictive index Operationalized asthma predictive index
Early frequent wheezer
Parental report-a value ≥3 in the scale (scale: 1 to 5, from "very rarely" to "on most days")
≥2 wheezing episodes at any given time on history or examination with at least 3 wks of interval Parental report (diagnosed by a physician)-Hay fever or any other condition that made a child's nose stuffy, itchy, or runny apart from colds during the first 3 yrs of life and whether a doctor had said that these symptoms were due to allergies.
Physician-diagnosed allergic rhinitis or hay fever documented 
| Proportion of children with wheezing episodes in various ranges of intervals of wheezing episodes
Only 60% among total wheezing episodes had an interval within 1 year between the first and subsequent wheezing episodes, but 73% within 2 years, and 81% within 3 years. The median interval of C-section, n (%) 10 (25) 3 (23) .88 a 9 children who met API but had minimal gap of wheezing episodes greater than 3 yrs were excluded.
wheezing episodes was 0.71 years (IQR, 0.26, 1.92; range, 0.05, 11.6).
| Characterization of intervals between wheezing episodes by age
The relationship between wheezing interval (ie, minimal wheezing interval for each patient) and age at the API index date is summarized in Figure 1 . The results showed that intervals between wheezing episodes increased with age (P < .001 for trends, ie, heteroskedasticity), possibly due to different biologic patterns of wheezing for a greater range of interval with age. Interestingly, there seems to be two clusters in patterns of wheezing intervals based on the timing of asthma onset (ie, API index date) which occurred after about 6 years of age (ie, Cluster A and B in Figure 1 ). Seven subjects in Cluster A with minimal wheezing intervals < 3 years had a range of 2-4 wheezing episodes, while only one of the seven subjects (14%) had a physician diagnosis of asthma and three subjects (43%)
showed favorable response to albuterol. On the other hand, all eight subjects in Cluster B with minimal wheezing interval > 3 years had a total of two wheezing episodes, but 50% of subjects had a physician diagnosis of asthma with 50% showing favorable response to albuterol, suggesting later onset of asthma may be associated with longer wheezing interval and less frequent wheezing episodes documented in the medical records.
| Age at the first wheezing episode (≤ 3 vs

>3 years of age) and minimal wheezing interval
We assessed whether or not age at the first wheezing episode is associated with minimal wheezing intervals. The majority of children (n = 55 [89%]) had their first wheezing episode at the age of 3 years or less (Figure 2) . Although the minimal wheezing interval of children who had the first wheezing episode before 3 years of life (Cluster 1) tended to be longer than those of children who had the first wheez- 
| DISCUSSION
To our knowledge, this is the first study that assessed the wheezing intervals and frequency in relation to age among children who met the criteria for asthma predictive index (API) based on medical records. Recurrent (2 or more) wheezing episodes within an interval of 3 years documented in medical records (ie, clinically more significant than parent-reported wheezing episodes in a survey questionnaire) as a prerequisite of API appear to be suitable for API to be applied to medical record-based retrospective studies in children (81% of wheezing episodes occur within a 3-year interval).
Apart from our previous studies, no study has assessed whether API can be used to ascertain asthma status in medical record-based retrospective studies. Identifying a suitable wheezing interval for API documented in medical records for children is important and warranted when one applies API to retrospective studies using medical records given the growing needs and trends of utilizing retrospective data based on medical records for asthma research. Furthermore, capturing wheezing episodes in preschoolers via parental report is challenging as parentally reported wheezing may be unreliable, 25 other conditions (eg, snoring, upper airway secretions, rattling sounds reflective of airway secretions or noisy breathing) could be misinterpreted as a wheeze, 26 and conventional pulmonary function testing is unavailable for children under the age of 5-6 years. In our F I G U R E 1 Correlation between minimal wheezing interval (in years) and the age at the API index date (ie, one wheezing interval per each subject included) F I G U R E 2 Pattern of minimal wheezing interval for each subject by age at the time of first wheezing episode (ie, one wheezing interval per each subject included)
ongoing study based on an independent study cohort from a birth cohort who met API (n = 64, mean age: 12.1 years (AE2.9)), we also observed similar findings that only 54% of wheezing intervals between wheezing episodes were within an interval of 1 year, but 81% were within 3 years. Thus, findings from our present and ongoing studies suggest that counting wheezing episodes within 1 year in ascertaining asthma status based on wheezing episodes documented in medical records appears to be too stringent as almost 40% of recurrent wheezing episodes occur beyond a one-year interval and wheezing episodes captured in medical records are likely to be clinically more significant or severe. A three-year interval to count the number of wheezing episodes to apply API to medical records needs to be considered regardless of the purpose of application of API (eg, asthma prediction during the first 3 years of life and asthma ascertainment beyond the first 3 years of life).
In support of this interpretation, our previous study extended the wheezing interval to 3 years and assessed asthma prevalence. 8 We found that the mean number of wheezing episodes per year documented for children with a physician diagnosis of asthma was 2 (95% CI: 1-3) during the first 3 years of life. 8, 9 Based on two or more wheezing episodes as a prerequisite for asthma ascertainment by API, 14% of children met the criteria for asthma, compared to 6% with 3 or more wheezing episodes. Yawn et al 27 reported that the prevalence of current asthma defined by a physician diagnosis and asthma-related visit within the past 2 years was 12.9% and that of asthma ever defined by a physician diagnosis ever was 17.9% in our community. In this present study, based on 2 or more wheezing episodes as a prerequisite for API, asthma prevalence is 14% consistent with the prevalence estimate of the study by Yawn et al and our previous study. Thus, asthma prevalence based on two or more wheezing episodes appears to be consistent with asthma prevalence in our community.
For the rationale for the 3-year interval, the literature typically defines remission of asthma as lack of asthma-related events (symptoms, medication, or medical visits) for 2 or 3 consecutive years. 28, 29 It implies that if one has active asthma, asthma symptoms (eg, B who had any asthma medications at the last follow-up date (57% vs 63%). The nature of clusters of children with regard to wheezing interval and age for meeting API needs to be further studied in a prospective study with a larger sample size. In addition, we demonstrated similarities between children who meet the API criteria based on a 1-year interval vs a 1-to 3-year interval in demographic and clinical characteristics (ie, known risk factors for asthma). However, the frequency of wheezing apart from cold and eosinophilia was different, potentially suggesting that extension of the interval for wheezing episodes might encompass heterogeneous subgroups of asthmatics in terms of biological and behavioral factors (eg, early onset vs later onset, atopic vs non-atopic asthma or greater vs less medical care/test-seeking behavior by parents and clinicians; Table 3 ).
The main implication of this study is to make API criteria available to retrospective studies based on medical records as the electronic medical record is increasingly utilized for clinical studies for asthma. In addition, retrospective API criteria can be utilized as a tool for clinical practice to identify children with asthma given the poor sensitivity of ICD codes. In addition to predetermined asthma criteria (PAC), another existing asthma criteria for retrospective studies developed by the renowned asthma researchers, Drs. John
Yunginger and Charles Reed, 15 proper use of retrospective API criteria in conjunction with PAC will potentially enhance asthma research and care.
The main strength of our study is the unique epidemiological advantages of our study setting including a self-contained health care environment and medical record linkage system under the auspices of the REP enabling us to capture all asthma-related events in medical records since birth. Another strength is the use of a population-based sampling frame including medical records of young children since birth, instead of a convenience sample. With these strengths, our present study was able to show study findings consistent with those of our previous study, which operationalized API for retrospective studies suggesting consistency.
Our study finding needs to be carefully interpreted because our study did not capture all wheezing episodes as parents whose children have mild respiratory illnesses including wheezing episodes typically do not seek medical evaluations. For example, our previous study showed 1 of 3 parents whose children had mild acute illnesses sought medical evaluation in our study setting (or 1 of 4 illnesses at a national level seeks medical care) (ie, differential healthcare access or care-seeking behavior). 22, 23 As this study did not capture all wheezing episodes, the nature of the systematic differences between wheezing associated with medical evaluation and those without medical evaluations is unknown. This needs to be studied in the future through a long-term prospective cohort study capturing all wheezing episodes regardless of clinic visits. For validation purpose (internal validity), we limited our study subjects to children who were born in and received medical care from Mayo Clinic to minimize the influence of heterogeneity of healthcare access on our study findings. Although the parent study of this study was based on a population-based birth cohort, the pattern of their wheezing episodes may not be generalizable to other populations as this cohort includes late-preterm children. However, as shown in the original study, 24 late preterm itself was not an independent risk factor for asthma. 24, [30] [31] [32] [33] [34] Also, our study sample size was relatively small. Thus, our study findings need to be replicated in an independent study with a larger sample size to support our conclusion.
In conclusion, the interval of wheezing episodes increases with age in children. To capture all childhood asthma including late-onset asthma, we suggest an interval of 3 years between wheezing episodes to define the frequency of wheezing episodes (2 or more) for application of API to retrospective research using medical records. Our results need to be replicated and further studied in future studies with a larger sample size for prospective estimation and clinical use.
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